Meet Our Urologists

2018 Departmental Highlights

Stern Joshua MD

Joshua Stern, MD was recently promoted within the department of Urology to Director of Endourology and the Kidney Stone Clinic.

Notably, Dr. Stern will also be presenting at the upcoming Research on Calculus Kinetics (R.O.C.K.) Society meeting in Rochester, NY on Saturday, April 14, 2018. The meeting is a specialty, invitation only meeting of kidney stone experts nationwide. Dr. Stern will give his presentation, Influence of the Gut Microbiome on Urinary Stone Disease Risk.

To learn more about Dr. Stern’s research, visit his profile.

The Urology research team at Montefiore and Einstein was ranked 16th in total 2017 National Institutes of Health (NIH) funding in the field of Urology by the Blue Ridge Institute for Medical Research, up from 23rd in 2016. Overall, investigators at Einstein and Montefiore secured $174 million from the NIH in the federal fiscal year 2017. Einstein ranks 7th in award dollars per investigator among the nation's top medical schools.

Guillermo Villegas, a post-doctoral fellow in the Laboratory of Kelvin Davies, PhD, recently won the best poster prize in the pre-clinical category at the International Society for Sexual Medicine meeting in Lisbon, Portugal. The poster, titled " Neuropraxia following nerve sparing radical prostatectomy is associated with increased expression of markers of inflammation and Fidgetin-2 like protein," was co-authored by Moses Tar, MD, Lisa Baker, David Sharp, PhD, and Kelvin Davies, PhD.

David Goldfarb, MD

David Goldfarb, MD, Professor of Medicine and Physiology, NYU School of Medicine, and Interim Chief, Nephrology Division, NYU Langone Health, presented at Urology Grand Rounds on Friday, March 2, 2018 in the Weiler Auditorium, Einstein Campus. Dr. Goldfarb is committed to patient care, teaching and kidney stone research, at NYU.

Dr. Goldfarb presented "Update on Nephrolithiasis" at 7:00 AM. He currently serves on the Medical Advisory Board of the National Kidney Foundation, the Scientific Advisory Board of the Oxalosis and Hyperoxaluria Foundation, and Board of Directors of the International Cystinuria Foundation. Dr. Goldfarb is the principal investigator of the "Rare Kidney Stone Consortium's Cystinuria Project," funded by the NIH.